# John R. Mackey

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-r-mackey/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,406 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 101 |
| i10-index | 280 |
| OpenAlex ID | https://openalex.org/A5032920417 |
| ORCID iD | https://orcid.org/0000-0002-3489-2161 |
| Works | 578 |

## Researcher papers

- [Adjuvant Trastuzumab in HER2-Positive Breast Cancer](https://scholariq.org/papers/adjuvant-trastuzumab-in-her2-positive-breast-cancer/)
- [The clonal and mutational evolution spectrum of primary triple-negative breast cancers](https://scholariq.org/papers/the-clonal-and-mutational-evolution-spectrum-of-primary-triple-negative-breast/)
- [Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment](https://scholariq.org/papers/sarcopenia-as-a-determinant-of-chemotherapy-toxicity-and-time-to-tumor/)
- [Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials](https://scholariq.org/papers/increasing-the-dose-intensity-of-chemotherapy-by-more-frequent-administration-or/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.